Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Alethia BioTherapeutics

Request full access

Immunotherapeutics against disease-specific targets

Montreal, CanadaFounded 2002Biotech & Life Sciences

About Alethia BioTherapeutics

Alethia Biotherapeutics is a biotechnology company focused on developing novel therapies for the treatment of invasive carcinomas. The company's core product, AB 16B5, is a humanized IgG2 antibody that targets and inhibits the epithelial to mesenchymal transition (EMT), a process that allows cancer cells to become more invasive and resistant to chemotherapy. By blocking EMT, AB 16B5 has shown in preclinical studies to increase the effectiveness of standard chemotherapy and reduce cancer cell invasion.

Alethia primarily serves the oncology market, targeting patients with advanced carcinomas who require more effective treatment options. The company operates within the biopharmaceutical industry, leveraging cutting-edge research and development to bring innovative cancer therapies to market.

Alethia's business model involves advancing its drug candidates through clinical trials, securing regulatory approvals, and ultimately partnering with larger pharmaceutical companies for commercialization. Revenue is generated through licensing agreements, milestone payments, and royalties on product sales.

Source: Dealroom company data

Alethia BioTherapeutics in the Montreal ecosystem

Live from Dealroom

The Alethia BioTherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇦 Canada100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Alethia BioTherapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Alethia BioTherapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.